Generic Release Date:

Menostar's generic launch date based on the expiry of its last outstanding patent is estimated to be Nov 21, 2017 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)

Menostar Generic API suppliers:

Estradiol is the generic name for the brand Menostar. 25 different companies have already filed for the generic of Menostar, with Mylan Technologies having the maximum number of approved applications. Check out the entire list of companies who have already received approval for Menostar's generic

Alternative Brands for Menostar

Menostar which is used for preventing postmenopausal osteoporosis., has several other brand drugs in the same treatment category and using the same active ingredient (Estradiol). Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.

Apart from brand drugs containing the same ingredient, some generics have also been filed for Estradiol, Menostar's active ingredient. Check the complete list of approved generic manufacturers for Menostar

Approval Date:

Menostar was approved by FDA for market use on 08 June, 2004.

Active Ingredient:

Menostar uses Estradiol as the active ingredient. Check out other Drugs and Companies using Estradiol ingredient

Treatment:

Menostar is used for preventing postmenopausal osteoporosis.

Dosage:

Menostar is available in system form for transdermal use. Given below is detailed information on Dosage -